Skip to main content
Livermore
Livermore
ZHEN

CX Institutional

SEC CIK
0001737089
Latest filing
Oct 2, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by CX Institutional, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q3 2026 holdings

Shares (Q3 2026)
1,888
Value
$987.0K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of VRTX by CX Institutional, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20261,888$987.0K<0.1%+50+2.7%AddedHolders
Q2 20261,838$913.0K<0.1%−102−5.3%ReducedHolders
Q1 20261,940$866.0K<0.1%+2+0.1%AddedHolders
Q4 20251,938$879.0K<0.1%+132+7.3%AddedHolders
Q3 20251,806$707.0K<0.1%+52+3.0%AddedHolders
Q2 20251,754$781.0K<0.1%−33−1.8%ReducedHolders
Q1 20251,787$866.0K<0.1%+148+9.0%AddedHolders
Q4 20241,639$660.0K<0.1%+11+0.7%AddedHolders
Q3 20241,628$757.1K<0.1%+3+0.2%AddedHolders
Q2 20241,625$761.7K<0.1%−18−1.1%ReducedHolders
Q1 20241,643$686.8K<0.1%−37−2.2%ReducedHolders
Q4 20231,680$683.6K<0.1%−21−1.2%ReducedHolders
Q3 20231,701$591.5K<0.1%−23−1.3%ReducedHolders
Q2 20231,724$606.7K<0.1%+3+0.2%AddedHolders
Q1 20231,721$543.8K<0.1%+425+32.8%AddedHolders
Q4 20221,296$374.3K<0.1%+95+7.9%AddedHolders
Q3 20221,201$348.0K<0.1%+480+66.6%AddedHolders
Q2 2022721$204.0K<0.1%+721NewHolders
Q4 20210$00.0%−47−100.0%Sold outHolders
Q3 202147$9.00K<0.1%−287−85.9%ReducedHolders
Q2 2021334$67.0K<0.1%−64−16.1%ReducedHolders
Q1 2021398$86.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.